D-Lysine

Specifications

N/A

Packing & Storage

Packing
Storage	Powder -20°C 3 years 4°C 2 years；In solvent -80°C 6 months, -20°C 1 month
Shipping	Room temperature in continental US; may vary elsewhere

Free Quote

For samples, pricing, or more information, please call us at 0086-25-52397805 or mail to info@alchemist-chem.com or fill out the following form.
We will respond to you as soon as possible.

Tel: 0086-25-52397805

Email: info@alchemist-chem.com

General Information

Chemical & Physical Properties

Safety Information

Synthetic Route

Biological Activity

Common Names	D-Leucine
Structure
CAS　No.	923-27-3	Boiling Point (℃)	311.5±32.0 °C at 760 mmHg
Molecular Weight	146.188	Melting Point (℃)	218ºC (dec.)
Density	1.0±0.1 g/cm3	Vapor Specific Gravity	N/A
Molecular Formula	C6H14N2O2	Flash Point (℃)	142.2±25.1 °C
Solubility	N/A	Autoignition Temperature (℃)	N/A

Personal Protective Equipment		Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes		T+:Very toxic
Safety Phrases		S1-S28-S45
RIDADR		NONH for all modes of transport
WGK Germany		3
	SYMPTOMS	PREVENTION	FIRST AID
Inhalation	Cough. Sore throat.	Use local exhaust or breathing protection.	Fresh air, rest.
Skin	Redness. Burning sensation. Itching.	Protective gloves.	Remove contaminated clothes. Rinse and then wash skin with water and soap.
Eyes	Redness. Pain.	Wear safety goggles.	First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.
Ingestion	Abdominal pain. Nausea. Vomiting.	Do not eat, drink, or smoke during work. Wash hands before eating.	Rinse mouth. Induce vomiting (ONLY IN CONSCIOUS PERSONS!). Refer for medical attention.

Description	D-Lysine is a useful raw material employed as an analog of lutenizing-hormone-releasing hormone and as a drug carrier in the form of polylysine. D-Lysine decreases renal uptake of radioactivity during scintigraphy and PRRT with low toxicity. D-Lysine not interferes with the natural amino acid metabolic balance[1][2].
Target	Human Endogenous Metabolite
In Vitro	DL-Lysine (Lys) is a high affinity, basic amino acid substrate for amino acid transporter b0,+ with Km value ranging from 100-400 μM[1].
References	[1]. Bernard BF, et al. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J Nucl Med. 1997 Dec;38(12):1929-33. [2]. Takahashi E, et al. D-lysine production from L-lysine by successive chemical racemization and microbial asymmetric degradation. Appl Microbiol Biotechnol. 1997 Apr;47(4):347-51.

Synonyms

(R)-2,6-Diaminocaproic acid
(R)-lysine
EINECS 213-091-9
Benzonitrile,2,6-diamino
D-Lysine
Lysine
D-2,6-Diaminohexanoic acid
(2R)-2,6-diaminohexanoic acid
(R)-2,6-Diaminohexanoic acid
r-lysine
MFCD00008234

Product Description

D-Lysine is an essential amino acid that has numerous applications in the pharmaceutical, food, and animal feed industries. In this analysis, we will explore the uses of D-Lysine in medicine, the upstream and downstream industries involved in its production, the current market trends, and the major chemical suppliers.
Uses of D-Lysine in medicine:
D-Lysine has been shown to have a variety of potential medical uses. It is commonly used as an ingredient in oral herpes treatments, as it has been shown to reduce the frequency and duration of outbreaks. Additionally, D-Lysine has been used to treat osteoporosis, as it has been shown to increase bone density and reduce the risk of fractures.
Upstream and downstream industries:
The production of D-Lysine involves a number of upstream and downstream industries. The primary raw material used in the production of D-Lysine is L-Lysine, which is produced through the fermentation process. Other upstream industries involved in the production of D-Lysine include the production of amino acids and other raw materials used in the fermentation process.
Downstream industries include the production of various pharmaceuticals that use D-Lysine as an ingredient. These include oral herpes treatments, osteoporosis medications, and other drugs that require the use of D-Lysine. The downstream industry also includes the production of animal feed supplements that contain D-Lysine.
Market trends:
The market for D-Lysine is expected to grow significantly in the coming years. This growth is primarily driven by the increasing demand for oral herpes treatments and osteoporosis medications. Additionally, the use of D-Lysine as an animal feed supplement is also expected to contribute to the growth of the market.
Chemical suppliers:
There are a number of chemical suppliers that produce and sell D-Lysine. Some of the major suppliers include CJ CheilJedang, Ajinomoto, and Evonik. These companies produce D-Lysine using various methods, including fermentation and chemical synthesis.
Conclusion:
D-Lysine is an important raw material for the production of a number of pharmaceutical products and animal feed supplements. Its potential benefits make it a valuable ingredient in the medical and food industries. The growing demand for oral herpes treatments and osteoporosis medications is expected to drive the growth of the market in the coming years.

Pharmaceutical Grade	Protecting Reagent	Protected Amino Acids
Food Grade	Feed Grade	Amino Acid Salts And Derivatives

Pharmaceutical Grade	Protecting Reagent	Protected Amino Acids
Food Grade	Feed Grade	Amino Acid Salts And Derivatives